Hansa Biopharma AB (OSTO:HNSA)
kr 40.72 +2.88 (+7.61%) Market Cap: 3.95 Bil Enterprise Value: 4.43 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 46/100

Hansa Biopharma AB Conference Call Transcript

May 27, 2026 / 12:00 PM GMT
Release Date Price: kr35.18 (+4.70%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HNSA.ST - Hansa Biopharma AB
Hansa Biopharma AB Conference Call
May 27, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to the Hansen Biopharma Conference Call.

All participants will be in a listen-only mode.

Should you need assistance, please signal a conference specialist by pressing the star key followed by zero.

After today's presentation, there will be an opportunity to ask questions.

To ask a question, you may press star then 1 on a touch tone phone.

To withdraw your question, please press star then 2.

Please note this event is being recorded.

I would now like to turn the conference over to Hansa Biopharma CEO, Renee Aguir-Lukander. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot